Work

P3‐329: SAM‐531, N,N‐dimethyl‐3‐{[3‐(1‐naphthylsulfonyl)‐1H‐indazol‐5‐yl]oxy} propan‐1‐amine, a novel serotonin‐6 receptor antagonist with preclinical pro‐cognitive efficacy

Year: 2010

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2010.05.1830

Authors: Thomas A. Comery, Suzan Aschmies, Simon Haydar, Zoe Hughes, Christine Huselton, Dianne Kowal, Angela Kramer, Geraldine McFarlane, Michael Monaghan, Deborah Smith, Guoming Zhang, Jean Zhang, Mei-Yi Zhang, Peter Reinhart, Al J. Robichaud, Menelas N. Pangalos

Institution: Pfizer (United States)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2159808111

FWCI: 0.22

Cites:

Cited by: 7

Related to: 10